Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,397 filings

Top spenders & firms Spend by issue

Clear
Q3
WHITMER & WORRALL, LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Pharmacy, Medicare/Medicaid, Copyright/Patent/Trademark
View →
Q3
EMD SERONO, INC. for EMD SERONO INC
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Veterans, Defense, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q3
CENCORA, INC. for CENCORA, INC.
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Taxation/Internal Revenue Code, Medicare/Medicaid, Pharmacy, Health Issues
View →
3T
LONG STRATEGIES, INC. for YC CONSULTING, LLC ON BEHALF OF PATIENTS RISING NOW
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $10,000.00 income
Copyright/Patent/Trademark, Defense, Health Issues, Pharmacy
View →
Q3
ARENTFOX SCHIFF LLP for PHARVARIS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $10,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q3
CVS HEALTH (AND SUBSIDIARIES) for CVS HEALTH (AND SUBSIDIARIES)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Pharmacy, Taxation/Internal Revenue Code, Medicare/Medicaid, Insurance
View →
Q3
FEROX STRATEGIES for FRESENIUS KABI USA LLC
3rd Quarter (July 1 - Sep 30) 2025 · Illinois · House · Senate · $50,000.00 income
Health Issues, Pharmacy, Trade (domestic/foreign)
View →
Q3
FEROX STRATEGIES for ELI LILLY AND COMPANY
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy
View →
2A
THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) for THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Labor Issues/Antitrust/Workplace, Medicare/Medicaid, Health Issues, Defense
View →
Q3
ASCENSION HEALTH ALLIANCE D/B/A ASCENSION for ASCENSION HEALTH ALLIANCE D/B/A ASCENSION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Budget/Appropriations
View →
Q3
BRIDGEBIO PHARMA, INC. for BRIDGEBIO PHARMA, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Pharmacy
View →
Q3
LMH STRATEGIC SOLUTIONS for TRAVERE THERAPEUTICS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · $20,000.00 income
Pharmacy
View →
Q3
BUCHANAN INGERSOLL & ROONEY PC for UNIVERSITY OF PITTSBURGH MEDICAL CENTER HEALTH PLAN
3rd Quarter (July 1 - Sep 30) 2025 · Pennsylvania · House · Senate · $50,000.00 income
Health Issues, Insurance, Medicare/Medicaid, Pharmacy
View →
Q3
BUCHANAN INGERSOLL & ROONEY PC for GENERIC ANIMAL DRUG ALLIANCE
3rd Quarter (July 1 - Sep 30) 2025 · Maryland · House · Senate
Animals, Health Issues, Medical/Disease Research/Clinical Labs, Pharmacy
View →
Q3
BUCHANAN INGERSOLL & ROONEY PC for BRIGHT PATH LABS
3rd Quarter (July 1 - Sep 30) 2025 · North Carolina · House · Senate · $30,000.00 income
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Manufacturing
View →
Q3
BUCHANAN INGERSOLL & ROONEY PC for BIOFLORIDA, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Florida · House · Senate · $20,000.00 income
Pharmacy, Budget/Appropriations, Copyright/Patent/Trademark, Health Issues
View →
Q3
ELEVANCE HEALTH, INC. for ELEVANCE HEALTH, INC.
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Health Issues, Insurance, Medicare/Medicaid, Pharmacy
View →
Q3
THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) for THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Defense, Pharmacy
View →
Q3
VANDERBILT UNIVERSITY MEDICAL CENTER for VANDERBILT UNIVERSITY MEDICAL CENTER
3rd Quarter (July 1 - Sep 30) 2025 · Tennessee · House · Senate
Budget/Appropriations, Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q3
ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Pharmacy, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q3
ARTEMIS POLICY GROUP LLC for NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION)
3rd Quarter (July 1 - Sep 30) 2025 · New York · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues, Insurance, Budget/Appropriations
View →
Q3
BOLD STRATEGIES, LLC for MORRIS & DICKSON CO., LLC
3rd Quarter (July 1 - Sep 30) 2025 · Louisiana · House · Senate · $10,000.00 income
Pharmacy, Health Issues
View →
Q3
ARTEMIS POLICY GROUP LLC for THE HEMOPHILIA ALLIANCE
3rd Quarter (July 1 - Sep 30) 2025 · Pennsylvania · House · Senate · $40,000.00 income
Medicare/Medicaid, Insurance, Pharmacy, Budget/Appropriations
View →
Q3
POWERS PYLES SUTTER & VERVILLE, P.C. for NATIONAL ASSOCIATION OF SPECIALTY PHARMACY
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $120,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q3
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) for MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS
3rd Quarter (July 1 - Sep 30) 2025 · Texas · House · Senate
Medicare/Medicaid, Pharmacy, Health Issues, Manufacturing
View →
Previous Page 18 of 56 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem